Momentum Stocks: China Biologic Products, Inc. (NASDAQ:CBPO), Exxon Mobil Corporation (NYSE:XOM), Sprint Corporation (NYSE:S), Rose Rock Midstream (NYSE:RRMS), Halozyme Therapeutics (NASDAQ:HALO)

On August 05, China Biologic Products, Inc. (NASDAQ:CBPO) reported total sales in the second quarter of 2015 increased by 31.6% to $79.1 million from $60.1 million in the same quarter of 2014. The increase was primarily attributable to increases in sales volume of major plasma-based products. China Biologic Products, Inc. (NASDAQ:CBPO) belongs to Healthcare sector. Its net profit margin is 29.50% and weekly performance is -11.69%. On last trading day company shares ended up $109.00. China Biologic Products, Inc. (NASDAQ:CBPO) distance from 50-day simple moving average (SMA50) is -5.67%.

A federal judge approved Exxon Mobil Corporation (NYSE:XOM)’s $5.07 million settlement of charges that it violated the federal Clean Water Act and state environmental laws in connection with a 2013 oil spill in central Arkansas. Exxon Mobil Corporation (NYSE:XOM) shares increased 1.68% in last trading session and ended the day at $78.79. XOM Gross Margin is 25.90% and its return on assets is 6.80%. Exxon Mobil Corporation (NYSE:XOM) quarterly performance is -8.12%.

On 12 August, SoftBank Group invested another $87 million in Sprint Corporation (NYSE:S), underscoring billionaire founder Masayoshi Son’s commitment to turning around the money-losing U.S. wireless carrier. Sprint Corporation (NYSE:S) belongs to Technology sector. Its net profit margin is -10.00% and weekly performance is 23.17%. On last trading day company shares ended up $3.88. Sprint Corporation (NYSE:S) distance from 50-day simple moving average (SMA50) is -5.32%.

Rose Rock Midstream, L.P. (NYSE:RRMS) will attend the 2015 Citi MLP/Midstream Infrastructure Conference in Las Vegas, NV on Wednesday, August 19 and Thursday, August 20, 2015. Rose Rock Midstream, L.P. (NYSE:RRMS) ended the last trading day at $36.09. Company weekly volatility is calculated as 7.71% and price to cash ratio as 99.83. Rose Rock Midstream, L.P. (NYSE:RRMS) showed a weekly performance of -0.85%.

On August 05, Halozyme Therapeutics, Inc. (NASDAQ:HALO) announced the appointment of Jeffrey W. Henderson to its board of directors. Henderson brings nearly 30 years of financial, commercial and pharmaceutical industry expertise to the board, most recently serving for almost 10 years as chief financial officer of $100-billion health care products and services company, Cardinal Health. Halozyme Therapeutics, Inc. (NASDAQ:HALO) belongs to Healthcare sector. Its net profit margin is -69.50% and weekly performance is -15.03%. On last trading day company shares ended up $19.90. Halozyme Therapeutics, Inc. (NASDAQ:HALO) distance from 50-day simple moving average (SMA50) is -9.74%.

Leave a Reply

Your email address will not be published. Required fields are marked *